Clyde W. Hodge

Clyde W. Hodge

Auto-generated profile, based on publicly available information

Clyde W. Hodge

University of North Carolina at Chapel Hill

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2007 in Pharmacology Biochemistry and Behavior
Verified
Journal Article
Closed access
FCFulton Crews
Fulton Crews
JHJun He
Jun He
CHClyde Hodge
Clyde Hodge

1 September 1999 in Neuron
Verified
Journal Article
Closed access
SKSachia G. Khasar
Sachia G. Khasar
YLYu-Huei Lin
Yu-Huei Lin
AMAnnick Martin
Annick Martin
JDJahan Dadgar
Jahan Dadgar
TMThomas McMahon
Thomas McMahon
MRMarisa Roberto
Marisa Roberto

1 November 1999 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
CHClyde W. Hodge
Clyde W. Hodge
KMKristin K. Mehmert
Kristin K. Mehmert
SKStephen P. Kelley
Stephen P. Kelley
TMThomas McMahon
Thomas McMahon
AHAshley Haywood
Ashley Haywood
MRMarisa Roberto
Marisa Roberto

1 December 2001 in Journal of Neuroscience
Verified
Journal Article
Closed access
PDF file
FOFoster Olive
Foster Olive
HKHeather N. Koenig
Heather N. Koenig
MNMichelle A. Nannini
Michelle A. Nannini
CHClyde W. Hodge
Clyde W. Hodge
Numerous studies have demonstrated that drugs of abuse activate the mesolimbic dopamine reward pathway, and it is widely held that this activation contributes to the motivational and positive reinforcing properties of these substances. However, there is evidence that endogenous opioid systems within this brain reward circuit also play a role in drug reinforcement and drug-seeking behavior. Using microdialysis in freely moving rats, we sought to determine whether various drugs of abuse (i.e., ethanol, cocaine, d-amphetamine, and nicotine) would increase neurotransmission of endogenous opioid peptides (i.e., endorphins) in the nucleus accumbens. Drugs were administered intraperitoneally twice at 3 h intervals, and the endorphin content of microdialysates was analyzed by a solid-phase radioimmunoassay. Acute administration of ethanol, cocaine, and d-amphetamine transiently elevated extracellular levels of endorphins in the nucleus accumbens, whereas nicotine and saline were without effect. We hypothesize that this drug-induced release of endorphins may contribute to the positive reinforcing and motivating properties of ethanol and psychostimulants.

1 May 2002 in Pharmacology Biochemistry and Behavior
Verified
Journal Article
Closed access
FOFoster Olive
Foster Olive
HKHeather N. Koenig
Heather N. Koenig
MNMichelle A. Nannini
Michelle A. Nannini
CHClyde W. Hodge
Clyde W. Hodge

16 February 1999 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
SKShera F. Kash
Shera F. Kash
LTLaurence H. Tecott
Laurence H. Tecott
CHClyde Hodge
Clyde Hodge
SBSteinunn Baekkeskov
Steinunn Baekkeskov
The larger isoform of the enzyme glutamate decarboxylase, GAD67, synthesizes >90% of basal levels of γ-aminobutyric acid (GABA) in the brain. In contrast, the smaller isoform, GAD65, has been implicated in the fine-tuning of inhibitory neurotransmission. Mice deficient in GAD65 exhibit increased anxiety-like responses in both the open field and elevated zero maze assays. Additionally, GAD65-deficient mice have a diminished response to the anxiolytics diazepam and pentobarbital, both of which interact with GABA-A receptors in a GABA-dependent fashion to facilitate GABAergic neurotransmission. Loss of GAD65-generated GABA does not appear to result in compensatory postsynaptic GABA-A receptor changes based on radioligand receptor binding studies, which revealed no change in the postsynaptic GABA-A receptor density. Furthermore, mutant and wild-type animals do not differ in their behavioral response to muscimol, which acts independently of the presence of GABA. We propose that stress-induced GABA release is impaired in GAD65-deficient mice, resulting in increased anxiety-like responses and a diminished response to the acute effects of drugs that facilitate the actions of released GABA.